Tata India Pharma and Healthcare Fund · Regular · Growth
NAV
₹33.4482
as of 16 Nov 2026
Expense Ratio
2.11%
AUM
₹1,534 Cr
Lumpsum returns (CAGR)
- 1Y
- +8.20%
- 3Y
- +16.50%
- 5Y
- +13.78%
- Since Inception
- +11.73%
SIP returns (XIRR)
- 1Y
- +14.86%
- 3Y
- +10.85%
- 5Y
- +15.83%
- Since Inception
- +15.83%
What history actually did — last 10 years (Nov 2016 – Nov 2026)
A ₹5,000 monthly SIP for the last 10 years (Nov 2016 – Nov 2026)
Real NAV backtest
A ₹5,000 monthly SIP would be worth ₹14,32,788 today — ₹6,00,000 invested, 16.8% XIRR.
₹6,00,000
Invested
₹14,32,788
Value today
16.8%
XIRR (p.a.)
A ₹1,00,000 lumpsum, the last 10 years (Nov 2016 – Nov 2026)
Real NAV backtest
₹1,00,000 invested 10 years ago would be ₹3,71,354 today (14.0% CAGR).
A regular withdrawal plan (SWP)
Real NAV backtest
A ₹10,00,000 corpus withdrawing ₹5,000/month since Nov 2016 would still hold ₹22,80,750.
Fund vs Benchmark (TRI)
Same SIP, benchmark total-return index
The same SIP would be worth ₹14,32,788 in this fund vs ₹12,00,785 in the benchmark — outperformance of ₹2,32,003.
Buying the worst day
Real NAV backtest
₹1,00,000 invested on the worst market day of the last 10 years (Nov 2016 – Nov 2026) (22 Mar 2020) would be ₹4,04,330 today (4.04×).
Historical simulation using actual published NAVs for the stated period. Past performance may or may not be sustained in the future. Not investment advice.
Risk Metrics
Trailing 1 year, annualised0.28
Sharpe Ratio
+0.04
Alpha
0.59
Beta
0.27
Sortino
11.54%
Std Dev
-11.22%
Max Drawdown
Performance Comparison
Sectoral allocation
as of 31 Oct 2026- Pharmaceuticals & Biotechnology63.70%
- Healthcare Services25.51%
- Fertilizers & Agrochemicals4.15%
- Chemicals & Petrochemicals3.51%
- Personal Products1.25%
- Food Products1.09%
- Healthcare Equipment & Supplies0.53%
Each sector links to the mutual funds most exposed to it.
Related reading
Thinking about Tata India Pharma and Healthcare Fund · Regular · Growth?
Talk to our AMFI-registered team — free, no pressure. We'll help you see if this fund fits your goals.
Compare with Similar Funds
Fund Details
Available transactions
Portfolio holdings
- 1Sun Pharmaceutical Industries Ltd7.89%
- 2Abbott India Ltd5.66%
- 3Divi Laboratories Ltd5.41%
- 4Healthcare Global Enterprises Ltd5.25%
- 5Dr Reddys Laboratories Ltd5.14%
- 6Torrent Pharmaceuticals Ltd4.73%
- 7Apollo Hospitals Enterprise Ltd4.55%
- 8Max Healthcare Institute Ltd4.28%
- 9Rainbow Childrens Medicare Ltd4.02%
- 10Sai Life Sciences Ltd3.22%
What this fund does
Tata India Pharma and Healthcare Fund · Regular · Growth invests in stocks from a specific sector or theme, offering concentrated exposure to a particular area of the economy. These funds carry sector-specific risks but can deliver significant returns when the underlying sector performs well.
About This Fund
Tata India Pharma and Healthcare Fund · Regular · Growth is a Sectoral / Thematic mutual fund offered by Tata Mutual Fund. The fund has been operational for over 10 years. It manages assets worth ₹1,534 Cr, reflecting investor confidence in the fund's strategy. It benchmarks its performance against BSE HEALTHCARE. The current expense ratio is 2.11%.
Who Should Invest?
- •Aggressive investors comfortable with significant short-term volatility
- •Investors with a long-term horizon of 7+ years who can ride out market cycles
- •SIP investors who can benefit from rupee cost averaging during market fluctuations